{"id":14597,"date":"2025-09-08T17:45:00","date_gmt":"2025-09-08T15:45:00","guid":{"rendered":"https:\/\/www.maunakeatech.com\/?p=14597"},"modified":"2025-09-08T17:24:18","modified_gmt":"2025-09-08T15:24:18","slug":"mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio","status":"publish","type":"post","link":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/","title":{"rendered":"Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio\u00a0"},"content":{"rendered":"\n<p class=\"has-text-align-center\"><strong><em>New letter published by the AFS highlights Cellvizio\u2019s superiority to conventional tools for detecting pre-cancerous tissue and dysplasia&nbsp;<\/em><\/strong><\/p>\n\n\n\n<p><strong>Paris and Boston, September 08, 2025 \u2013 5:45 p.m. CEST \u2013 Mauna Kea Technologies (Euronext Growth: ALMKT)<\/strong>, inventor of Cellvizio<sup>\u00ae<\/sup>, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p\/nCLE) platform, today announces that the American Foregut Society (AFS), a leading society of gastroenterologists and surgeons collaborating to improve patient outcomes of several conditions, including esophageal disease, has issued a new comprehensive letter<sup>1 <\/sup>strongly advocating for broad reimbursement coverage of Cellvizio and confocal laser endomicroscopy (CLE) from commercial payors.&nbsp;<\/p>\n\n\n\n<p>The letter highlights compelling clinical and economic data evidence, published recently, demonstrating Cellvizio\u2019s overwhelming sensitivity to the current \u201cgold standard\u201d of random biopsies (Seattle protocol four-quadrant biopsies) for patients with Barrett\u2019s esophagus, a precursor to esophageal cancer, and dysplasia detection.&nbsp;<\/p>\n\n\n\n<p>Often considered as a non-followed gold standard, the Seattle protocol suffers from multiple issues leading to significant sampling error and missed diagnoses. The letter concludes that adjunctive use of Cellvizio leads to more accurate and timely diagnosis, enhances cost efficiency, and ultimately provides physicians with a greater range of options for patient management and treatment through earlier detection.&nbsp;<\/p>\n\n\n\n<p>This advocacy reflects the society\u2019s recognition that despite overwhelming clinical evidence supporting Cellvizio, coverage limitations have prevented many patients from receiving the most accurate diagnostic evaluation available. As a result, the AFS strongly calls for broad reimbursement coverage of Cellvizio and CLE from commercial payors, so that all patients at risk for Barrett\u2019s esophagus and pre-cancerous changes have access to a comprehensive examination and endoscopic treatment prior to progression to esophageal cancer.&nbsp;<\/p>\n\n\n\n<p><strong>Sacha Loiseau, Chairman and CEO of Mauna Kea Technologies<\/strong>, added: <em>&#8220;On behalf of the millions of patients suffering from reflux disease, we applaud the AFS and look forward to working with payors to expand further the coverage of Cellvizio, ultimately broadening patient access to our breakthrough imaging platform. This endorsement builds on the commercial momentum we established in the U.S. during the first&nbsp;half, which has continued in the current quarter across both capital sales and our pay-per-use business\u201d.&nbsp;<\/em><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n<p><br><sub><sup>1<\/sup><\/sub> <a href=\"https:\/\/www.americanforegutsociety.org\/assets\/docs\/research\/AFS%20Position%20Paper-%20CLE%20.docx\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.americanforegutsociety.org\/assets\/docs\/research\/AFS%20Position%20Paper-%20CLE%20.docx&nbsp;<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2025\/09\/PR_ALMKT_AFS-Letter_EN.pdf\">READ THE COMPLETE PRESS RELEASE<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>New letter published by the AFS highlights Cellvizio\u2019s superiority to conventional tools for detecting pre-cancerous tissue and dysplasia&nbsp; Paris and Boston, September 08, 2025 \u2013 5:45 p.m. CEST \u2013 Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio\u00ae, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p\/nCLE) platform, today announces that the American Foregut Society [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":4312,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[34],"tags":[],"class_list":["post-14597","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-int"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio\u00a0 - Mauna Kea Technologies<\/title>\n<meta name=\"description\" content=\"The American Foregut Society (AFS), a leading society of gastroenterologists and surgeons collaborating to improve patient outcomes of several conditions, including esophageal disease, has issued a new comprehensive letter strongly advocating for broad reimbursement coverage of Cellvizio and confocal laser endomicroscopy (CLE) from commercial payors.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio\u00a0 - Mauna Kea Technologies\" \/>\n<meta property=\"og:description\" content=\"The American Foregut Society (AFS), a leading society of gastroenterologists and surgeons collaborating to improve patient outcomes of several conditions, including esophageal disease, has issued a new comprehensive letter strongly advocating for broad reimbursement coverage of Cellvizio and confocal laser endomicroscopy (CLE) from commercial payors.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/\" \/>\n<meta property=\"og:site_name\" content=\"Mauna Kea Technologies\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/maunakeatech\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-08T15:45:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/973dee6eb0be799bb8f6a4ce50ddd711b01d8001.png\" \/>\n\t<meta property=\"og:image:width\" content=\"330\" \/>\n\t<meta property=\"og:image:height\" content=\"192\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Elizabeth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:site\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Elizabeth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/\"},\"author\":{\"name\":\"Elizabeth\",\"@id\":\"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82\"},\"headline\":\"Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio\u00a0\",\"datePublished\":\"2025-09-08T15:45:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/\"},\"wordCount\":396,\"image\":{\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/973dee6eb0be799bb8f6a4ce50ddd711b01d8001.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"int\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/\",\"url\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/\",\"name\":\"Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio\u00a0 - Mauna Kea Technologies\",\"isPartOf\":{\"@id\":\"https:\/\/www.maunakeatech.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/973dee6eb0be799bb8f6a4ce50ddd711b01d8001.png\",\"datePublished\":\"2025-09-08T15:45:00+00:00\",\"author\":{\"@id\":\"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82\"},\"description\":\"The American Foregut Society (AFS), a leading society of gastroenterologists and surgeons collaborating to improve patient outcomes of several conditions, including esophageal disease, has issued a new comprehensive letter strongly advocating for broad reimbursement coverage of Cellvizio and confocal laser endomicroscopy (CLE) from commercial payors.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#breadcrumb\"},\"inLanguage\":\"int\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"int\",\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#primaryimage\",\"url\":\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/973dee6eb0be799bb8f6a4ce50ddd711b01d8001.png\",\"contentUrl\":\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/973dee6eb0be799bb8f6a4ce50ddd711b01d8001.png\",\"width\":330,\"height\":192},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.maunakeatech.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.maunakeatech.com\/#website\",\"url\":\"https:\/\/www.maunakeatech.com\/\",\"name\":\"Mauna Kea Technologies\",\"description\":\"See Cells. Change Lives.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.maunakeatech.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"int\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82\",\"name\":\"Elizabeth\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"int\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g\",\"caption\":\"Elizabeth\"},\"url\":\"https:\/\/www.maunakeatech.com\/int\/author\/elizabeth\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio\u00a0 - Mauna Kea Technologies","description":"The American Foregut Society (AFS), a leading society of gastroenterologists and surgeons collaborating to improve patient outcomes of several conditions, including esophageal disease, has issued a new comprehensive letter strongly advocating for broad reimbursement coverage of Cellvizio and confocal laser endomicroscopy (CLE) from commercial payors.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/","og_locale":"en_US","og_type":"article","og_title":"Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio\u00a0 - Mauna Kea Technologies","og_description":"The American Foregut Society (AFS), a leading society of gastroenterologists and surgeons collaborating to improve patient outcomes of several conditions, including esophageal disease, has issued a new comprehensive letter strongly advocating for broad reimbursement coverage of Cellvizio and confocal laser endomicroscopy (CLE) from commercial payors.\u00a0","og_url":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/","og_site_name":"Mauna Kea Technologies","article_publisher":"https:\/\/www.facebook.com\/maunakeatech\/","article_published_time":"2025-09-08T15:45:00+00:00","og_image":[{"width":330,"height":192,"url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/973dee6eb0be799bb8f6a4ce50ddd711b01d8001.png","type":"image\/png"}],"author":"Elizabeth","twitter_card":"summary_large_image","twitter_creator":"@maunakeatech","twitter_site":"@maunakeatech","twitter_misc":{"Written by":"Elizabeth","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#article","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/"},"author":{"name":"Elizabeth","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82"},"headline":"Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio\u00a0","datePublished":"2025-09-08T15:45:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/"},"wordCount":396,"image":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/973dee6eb0be799bb8f6a4ce50ddd711b01d8001.png","articleSection":["News"],"inLanguage":"int"},{"@type":"WebPage","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/","url":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/","name":"Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio\u00a0 - Mauna Kea Technologies","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#primaryimage"},"image":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/973dee6eb0be799bb8f6a4ce50ddd711b01d8001.png","datePublished":"2025-09-08T15:45:00+00:00","author":{"@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82"},"description":"The American Foregut Society (AFS), a leading society of gastroenterologists and surgeons collaborating to improve patient outcomes of several conditions, including esophageal disease, has issued a new comprehensive letter strongly advocating for broad reimbursement coverage of Cellvizio and confocal laser endomicroscopy (CLE) from commercial payors.\u00a0","breadcrumb":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#breadcrumb"},"inLanguage":"int","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/"]}]},{"@type":"ImageObject","inLanguage":"int","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#primaryimage","url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/973dee6eb0be799bb8f6a4ce50ddd711b01d8001.png","contentUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/973dee6eb0be799bb8f6a4ce50ddd711b01d8001.png","width":330,"height":192},{"@type":"BreadcrumbList","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-strong-advocacy-from-the-american-foregut-society-afs-for-broad-reimbursement-coverage-from-u-s-commercial-payors-for-cellvizio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.maunakeatech.com\/"},{"@type":"ListItem","position":2,"name":"Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.maunakeatech.com\/#website","url":"https:\/\/www.maunakeatech.com\/","name":"Mauna Kea Technologies","description":"See Cells. Change Lives.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.maunakeatech.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"int"},{"@type":"Person","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82","name":"Elizabeth","image":{"@type":"ImageObject","inLanguage":"int","@id":"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g","caption":"Elizabeth"},"url":"https:\/\/www.maunakeatech.com\/int\/author\/elizabeth\/"}]}},"_links":{"self":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/14597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/comments?post=14597"}],"version-history":[{"count":1,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/14597\/revisions"}],"predecessor-version":[{"id":14599,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/14597\/revisions\/14599"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/media\/4312"}],"wp:attachment":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/media?parent=14597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/categories?post=14597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/tags?post=14597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}